Spruce Biosciences Inc. (SPRB) Social Stream



Spruce Biosciences Inc. (SPRB): $2.11

-0.04 (-1.86%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SPRB to Watchlist
Sign Up

Industry: Biotech


Ranked

of 390

in industry

Spruce Biosciences Inc (SPRB) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Spruce Biosciences Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-12 2 $44 $30 $36.333 $2.13 1605.77%
2021-11-16 3 $44 $5 $23 $2.13 979.81%
2021-12-10 4 $20 $5 $10.666 $2.13 400.75%
2022-01-25 5 $20 $5 $11.75 $2.13 451.64%
2022-03-15 6 $20 $5 $10.2 $2.13 378.87%
2022-03-28 6 $20 $3 $9.8 $2.13 360.09%

The Trend in the Analyst Price Target


Over the past 17 months, SPRB's average price target has gone down $23.95.

Over the past 50 weeks, SPRB's average upside potential has been 307.5%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 1 44 26 33.25 17.07 94.79%
2021-07-17 1 44 26 33.00 9.91 233%
2021-09-09 4 44 26 32.20 7.83 311.24%
2021-11-16 3 20 5 12.50 3.08 305.84%
2021-12-17 5 20 5 11.75 5.03 133.6%

SPRB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 4 0 2 0 0 6

The Trend in the Broker Recommendations


Over the past 59 days, SPRB's average broker recommendation rating improved by 0.13.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Spruce Biosciences Inc's upside potential (average analyst target price relative to current price) is higher than 1154.77% of them.
  • In the context of all US stocks, Spruce Biosciences Inc's variance in analysts' estimates is lower than -973.12% of them.
  • In the context of stocks in the small market cap category, Spruce Biosciences Inc's average analyst price target is greater than 410.84% of them.
  • SPRB has a higher number of analysts covering the stock than 342.75% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Spruce Biosciences Inc are SNSE, SNDX, and SMMT.

Is SPRB a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.49 seconds.